🔗 Share this article

The top legal official in Texas Ken Paxton is suing the producers of acetaminophen, claiming the corporations hid alleged dangers that the medication presented to children's brain development.

This legal action arrives thirty days after President Donald Trump advocated an unsubstantiated connection between using Tylenol - alternatively called acetaminophen - while pregnant and autism spectrum disorder in young ones.

Paxton is taking legal action against Johnson & Johnson, which formerly manufactured the medication, the sole analgesic recommended for women during pregnancy, and Kenvue, which presently makes it.

In a official comment, he said they "deceived the public by making money from discomfort and promoting medication regardless of the dangers."

Kenvue asserts there is lacking scientific proof linking Tylenol to autism spectrum disorder.

"These manufacturers misled for generations, deliberately risking numerous people to boost earnings," the attorney general, a Republican, said.

The manufacturer said in a statement that it was "very worried by the perpetuation of misinformation on the reliability of acetaminophen and the likely effects that could have on the health of American women and children."

On its official site, the company also mentioned it had "continuously evaluated the applicable studies and there is no credible data that demonstrates a proven link between taking paracetamol and autism."

Associations representing doctors and healthcare providers concur.

The American College of Obstetricians and Gynecologists has said paracetamol - the main ingredient in acetaminophen - is one of the few options for women during pregnancy to manage discomfort and fever, which can pose major wellness concerns if left untreated.

"In more than two decades of investigation on the consumption of paracetamol in pregnancy, zero credible investigations has successfully concluded that the usage of acetaminophen in any stage of gestation causes brain development issues in children," the association commented.

This legal action references latest statements from the former administration in asserting the medication is potentially dangerous.

Recently, Trump raised alarms from public health officials when he instructed expectant mothers to "resist strongly" not to use Tylenol when ill.

Federal regulators then published an announcement that physicians should contemplate reducing the usage of Tylenol, while also declaring that "a direct connection" between the medication and autism in minors has not been proven.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had pledged in April to initiate "a massive testing and research effort" that would establish the cause of autism in a short period.

But authorities warned that discovering a single cause of autism - believed by scientists to be the outcome of a complicated interplay of inherited and surrounding conditions - would prove challenging.

Autism spectrum disorder is a category of enduring cognitive variation and impairment that affects how individuals perceive and engage with the world, and is diagnosed using doctors' observations.

In his court filing, Paxton - aligned with the former president who is seeking federal office - asserts Kenvue and J&J "deliberately disregarded and attempted to silence the science" around paracetamol and autism spectrum disorder.

The case attempts to require the corporations "destroy any marketing or advertising" that claims acetaminophen is reliable for pregnant women.

The court case parallels the concerns of a assembly of guardians of young ones with autism and attention deficit hyperactivity disorder who took legal action against the producers of Tylenol in recently.

Judicial authorities rejected the case, declaring research from the parents' expert witnesses was lacking definitive proof.